Flagship Ventures, a healthcare-focused venture firm, has closed its fifth fund at $537 million.
The Cambridge, Massachusetts-based VC did not disclose a target for Fund V. Dr. Noubar Afeyan, a Flagship senior MD and CEO, said in a statement that the fifth fund closed with nearly twice the amount of capital the firm initially sought. Including the new pool, Flagship said it has $1.4 billion in funds under management.
Flagship Ventures Fund V will focus on backing early-stage companies in therapeutics, health technologies and sustainability, specifically in the energy, water, and agriculture/nutrition sectors.
In early January 2012, Flagship announced that it had closed its fourth fund at $270 million, beating its $250 million target. No performance data was available.
Flagship said Thursday it also promoted Dr. Douglas Cole to managing partner and Dr. David Berry to general partner.
Photo courtesy of Shutterstock.